On May 31, 2026, the 22nd IFOSMA Congress and the 3rd “Integration · Innovation” Joint Conference concluded successfully in Wuxi, China. Bringing together leading sports medicine experts from around the world, the congress focused on emerging technologies, precision clinical applications, and the integration of research, education, and industry.

As one of the key academic platforms in China’s sports medicine community, IFOSMA continues to promote international exchange and clinical innovation. Delta Medical participated throughout the event, presenting its latest advancements in sports medicine solutions.

At the exhibition, Delta Medical showcased a comprehensive portfolio covering sports medicine implants, surgical instruments, and arthroscopy systems. Designed to support precise, minimally invasive, and efficient procedures, the company’s solutions attracted significant interest from clinicians and industry professionals.

A key highlight was Delta Medical’s hip arthroscopy solution, featuring specialized implants and instruments developed to address evolving clinical needs. Guided by a clinician-oriented innovation strategy, Delta Medical continues to expand its product ecosystem across shoulder, knee, ankle, elbow, hip, and spine procedures, while also advancing biologic treatment solutions. Driven by innovation, quality manufacturing, and clinical value, Delta Medical remains committed to delivering high-quality sports medicine products and integrated solutions. Looking ahead, the company will continue collaborating with healthcare professionals worldwide to support the advancement of sports medicine and improve patient outcomes.